Logo Université LavalLogo Université Laval
Bibliothèque
Pour savoir comment effectuer et gérer un dépôt de document, consultez le « Guide abrégé – Dépôt de documents » sur le site Web de la Bibliothèque. Pour toute question, écrivez à corpus@ulaval.ca.
 

Personne :
Hynes, Alexander

Photo de profil

Adresse électronique

Date de naissance

Projets de recherche

Structures organisationnelles

Fonction

Nom de famille

Hynes

Prénom

Alexander

Affiliation

Université Laval. Département de biochimie, de microbiologie et de bio-informatique

ISNI

ORCID

Identifiant Canadiana

ncf13721076

person.page.name

Filtres

20142
Réinitialiser les filtres

Paramètres

Depuis: 2014 × Jusque: 2014 × Type d'Item: Publication ×

Résultats de recherche

Voici les éléments 1 - 2 sur 2
  • PublicationRestreint
    CRISPR-Cas systems : making the cut
    (American Society for Microbiology, 2014-05-01) Moineau, Sylvain; Hynes, Alexander
  • PublicationAccès libre
    Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages
    (Nature Publishing Group, 2014-07-24) Moineau, Sylvain; Hynes, Alexander; Villion, Manuela
    Clustered regularly interspaced short palindromic repeats (CRISPRs) and their associated cas genes serve as a prokaryotic ‘adaptive’ immune system, protecting against foreign DNA elements such as bacteriophages. CRISPR-Cas systems function by incorporating short DNA ‘spacers’, homologous to invading DNA sequences, into a CRISPR array (adaptation). The array is then transcribed and matured into RNA molecules (maturation) that target homologous DNA for cleavage (interference). It is unclear how these three stages could occur quickly enough in a naive phage-infected cell to interfere with phage replication before this cell would be irrevocably damaged by the infection. Here we demonstrate that cells can acquire spacers from defective phages at a rate directly proportional to the quantity of replication-deficient phages to which the cells are exposed. This process is reminiscent of immunization in humans by vaccination with inactivated viruses.